학술논문

Impact of Sars‐CoV‐2 pandemic on psoriatic patients.
Document Type
Article
Source
Journal of Cosmetic Dermatology. Feb2023, Vol. 22 Issue 2, p679-685. 7p.
Subject
*COVID-19 pandemic
*PSORIATIC arthritis
*VACCINATION complications
Language
ISSN
1473-2130
Abstract
N (%)No12 (80.0)89 (85.6)0.70Yes, that treatment can favor vaccine adverse reaction.3 (20.0)7 (6.7)0.11Yes, that treatment can reduce vaccine effectiveness0 (0.0)4 (3.9)1.00Yes, both0 (0.0)4 (3.9)1.00Do you consider yourself a "fragile patient" who should have a priority for vaccination? Overall, 31% of patients considered themselves as "fragile patients" who needed to receive Sars-CoV-2 vaccine with a priority for their skin condition (10%), for psoriasis treatment (7.6%), for both (1.7%) and for their comorbidities (11.8%). N (%)No73 (90.1)28 (73.7)0.02Yes, that treatment can favor vaccine adverse reaction.6 (7.4)4 (10.5)0.72Yes, that treatment can reduce vaccine effectiveness2 (2.5)2 (5.3)0.59Yes, both0 (0.0)4 (10.5)0.009Do you consider yourself a "fragile patient" who should have a priority for vaccination?. [Extracted from the article]